Matches in Nanopublications for { ?s ?p "[Although H&H combination treatment (high active TIL and high sensitive drugs) as previously described to solid tumor patients is more efficient than single-agent treatments such as TIL adoptive immunotherapy, it has a short-term efficiency for the immune response to metastatic cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP789506.RA3Xh4Su-hWU6gQi11bJ9b1FauHNHb8Y_MLQrlYq58HPQ130_assertion description "[Although H&H combination treatment (high active TIL and high sensitive drugs) as previously described to solid tumor patients is more efficient than single-agent treatments such as TIL adoptive immunotherapy, it has a short-term efficiency for the immune response to metastatic cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789506.RA3Xh4Su-hWU6gQi11bJ9b1FauHNHb8Y_MLQrlYq58HPQ130_provenance.
- NP739773.RAgYdTpDk4ChadwDSZ4HUCfKeeQVoof1I-cYJFQygB8WQ130_assertion description "[Although H&H combination treatment (high active TIL and high sensitive drugs) as previously described to solid tumor patients is more efficient than single-agent treatments such as TIL adoptive immunotherapy, it has a short-term efficiency for the immune response to metastatic cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739773.RAgYdTpDk4ChadwDSZ4HUCfKeeQVoof1I-cYJFQygB8WQ130_provenance.